SurModics (NYSE: SRDX) — Perfil da empresa, notícias e dados financeiros
SurModics develops surface modification and drug delivery technologies to enhance medical device performance in healthcare.
SurModics
SurModics (NASDAQ:SRDX) specializes in the development and commercialization of surface modification and drug delivery technologies. These advancements empower medical devices and in vitro diagnostics to perform more effectively, which in turn, supports healthcare professionals in providing better care. With a keen focus on innovation, SurModics endeavors to tackle unmet medical needs by enhancing the performance and reliability of medical devices. Their projects range from coating technologies that improve the functionality and compatibility of medical devices to drug-coated balloons for the treatment of peripheral arterial disease. With objectives firmly set on advancing healthcare solutions, SurModics is committed to pushing the boundaries of medical technology to improve patient outcomes and create value for its stakeholders.
Resumo
Operações
Produtos e/ou serviços de SurModics
- Drug-coated balloons for peripheral and coronary artery diseases, delivering therapeutic agents directly to the vessel wall.
- Medical device coatings to improve the biocompatibility and functionality of devices.
- Gene delivery technologies for precisely targeted therapy in retinal diseases.
- PhotoLink, a technology that enhances medical device surfaces for improved performance and longevity.
- Radiofrequency ablation products for the treatment of certain forms of cancer, utilizing thermal energy.
- Hydrophilic coatings that reduce friction and improve the durability of medical devices, enhancing patient comfort and device efficacy.
equipe executiva do SurModics
- Mr. Gary R. MaharajCEO, President & Director
- Mr. Timothy J. ArensSenior VP of Finance & Information Technology and CFO
- Mr. Gordon S. Weber J.D.Senior VP of Legal, General Counsel & Secretary
- Mr. Charles W. OlsonSenior VP & President of Medical Device Coatings
- Ms. Teryl L. W. SidesSenior VP & President of Vascular Interventions
- Mr. John D. MandersCorporate Controller, VP of Finance & Principal Accounting Officer
- Joel SuiterDirector of Corporate Development
- Mr. Joseph J. StichSenior VP of Human Resources & President of In Vitro Diagnostics
Principais indicadores financeiros
Resultados divulgados pela SurModics, em USD.
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 126,1 mi | -5,6 mi | -11,5 mi | |
| 132,6 mi | 5,2 mi | -1,5 mi | |
| 100 mi | -22,1 mi | -27,3 mi | |
| 105,1 mi | 6,7 mi | 4,2 mi |